SYNLOGIC, INC. Shareholders' Equity
SYNLOGIC, INC. (SYBX) had Shareholders' Equity of $12.02 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.02M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.55M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $11.86M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $10.32M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.02M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $12.55M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $11.86M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $10.32M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $12.59M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $13.09M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $12.75M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $13.11M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $13.12M 10-Q · filed 2025-11-13 | $15.98M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $9.40M 10-Q · filed 2025-08-07 | $13.32M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $32.77M 10-K · filed 2026-03-12 | $42.66M 10-K · filed 2024-03-19 |
| 2023-09-30 | $43.40M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $54.77M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $68.71M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $82.61M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $100.43M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $117.35M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $132.29M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $147.27M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $161.58M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $128.08M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $109.05M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $115.14M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $120.50M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $131.67M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $142.12M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $156.91M 10-K · filed 2022-03-17 | |
| 2019-09-30 | $168.67M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $180.82M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $112.21M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $124.10M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $135.03M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $144.62M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $128.77M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $85.04M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $95.56M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $46.70M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $55.75M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $8.50M 10-K · filed 2019-03-12 | $60.35M 10-K · filed 2017-03-15 |
| 2016-09-30 | $68.64M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $73.51M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $78.90M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $977.00K 10-K · filed 2018-03-20 | $85.02M 10-K · filed 2016-03-30 |
| 2015-09-30 | -$67.73M 10-Q · filed 2015-11-13 | |
| 2014-12-31 | -$47.95M 10-K · filed 2017-03-15 | |
| 2013-12-31 | -$29.91M 10-K · filed 2017-03-15 | |
| 2012-12-31 | -$24.37M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |